PT-141 10 Deus Medical

Active Pharmaceutical Ingredient:

Bremelanotide Pack:1 Vial x / 10 Mg

Form:Injectable

Overview of PT-141 (Bremelanotide)

PT-141, or Bremelanotide, is a medication employed primarily to treat Hypoactive Sexual Desire Disorder (HSDD) in men and women. It is supplied as a 10 mg/vial injectable solution containing Bremelanotide and excipients. Unlike other therapies that involve hormonal pathways, PT-141 directly targets the sexual response system of the brain, hence making it a new and effective libido-enhancing therapy.

Mechanism of Action
PT-141 is a melanocortin receptor agonist that stimulates melanocortin receptors (M1-M5) within the brain. It causes sexual arousal and desire with no dependency on hormonal changes. It is most effective for those who have no existing medical condition that affects their sexuality.

Dosage and Administration
The treatment is a single subcutaneous dose (10 mg) 45 minutes to 2 hours before sexual intercourse. The effects can last several hours, opening a window of enhanced libido and performance.

Side Effects
Common side effects of PT-141 are:

Nausea and vomiting

Headache

Injection site reactions (redness, swelling, or pain)

Flushing

Cough

These side effects are generally mild and transient. However, if they turn severe or persistent, medical care should be sought.

Drug Interactions
PT-141 may have interaction with certain medications, such as:

COX inhibitors (e.g., ibuprofen, aspirin)

Naltrexone (for opioid or alcohol dependency)

Always inform your healthcare provider of any medications or supplements that you are taking in order to avoid interactions.

Source:

https://deusmedical.com/products/peptides-and-hgh/pt-141/